Intraocular methotrexate for epithelial downgrowth: long-term outcomes in a multicentre case series. Hebert M, Kyrillos R, Snyder ME, Mackool RJ, et al. Br J Ophthalmol 2022 Jun 1. pii: bjophthalmol-2022-321168.

Read + Share

Amedeo Smart

Independent Medical Education

Hebert M, Kyrillos R, Snyder ME, Mackool RJ, et al. Intraocular methotrexate for epithelial downgrowth: long-term outcomes in a multicentre case series. Br J Ophthalmol 2022 Jun 1. pii: bjophthalmol-2022-321168.
PMID: 35649694